Sleep Device Articles & Analysis
11 news found
Brandon Nokes, Professor Atul Malhotra, and other collaborators, is based on a post-hoc analysis of 65 participants with mild obstructive sleep apnea (OSA) who completed sleep testing before and after six weeks of genioglossus (tongue muscle) neuromuscular electrical stimulation (NMES) with eXciteOSA. ...
” Lipman joins Bodyport with more than 25 years of leadership experience, including developing and leading pre-launch and commercial companies across the medical device industry. “I am delighted to welcome John to the team during this important phase of our growth,” Centen said. ...
Signifier is the developer of the revolutionary eXciteOSA® medical device for the treatment of sleep disordered breathing, which has now been launched in key markets including the United States of America, Canada, the United Kingdom and Germany. Nearly one billion adults aged 30 to 69 years globally are estimated to suffer from OSA (Obstructive ...
Of the latest funding boost, Mr McKeown said: “The business has grown rapidly over the last few years and it is an exciting time as we continue to expand in the American market. Our new product Modius Sleep is a drug-free non-invasive headset that actively stimulates key sleep neurons in the brain to improve sleep. ...
AcuPebble SA100, a small wearable device that enables automated, remote home testing to detect obstructive sleep apnoea (OSA) in adults, has obtained FDA 510(k) clearance as a Class II medical device in the USA. The device, which received a CE Mark as a Class IIa medical device in 2020, was developed and is ...
Signifier Medical Technologies Ltd, an innovator in the sleep-disordered breathing market, announced today that it has hit the 50,000 therapy session milestone with its innovative eXciteOSA® sleep device. ...
Signifier Medical Technologies, an innovator in the sleep disordered breathing market, today announced that eXciteOSA®, the first and only daytime intraoral neuromuscular stimulation device for treating mild obstructive sleep apnea and snoring, has received the prestigious GOOD DESIGN® Award in the Medical category. ...
Signifier Medical Technologies, an innovator in the sleep disordered breathing market, today announced that eXciteOSA®, the first and only daytime intraoral neuromuscular stimulation device for treating mild obstructive sleep apnea and snoring, has been cleared by the U.S. Food and Drug Administration (FDA), giving millions of sufferers in ...
Drexler continues to serve on the board for ResMed, a market leader in digital health devices that track sleep and other respiratory conditions like asthma and COPD. ...
” Earlier this year, Sommetrics announced its sleep apnea therapy system, aerSleepTM, received Health Canada approval, allowing it to be marketed in Canada. aerSleepTM is the first device to use negative external air pressure to successfully treat obstructive sleep apnea, a disorder that affects more than 20 percent of adults worldwide. ...
“The process to create this sleep apnea screening device is complex, but the idea is simple: Zansors making affordable, easy-to-use diagnostic tools so people can be proactive about their health. ...